Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTIs in AGS
NCT02363452Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zidovudine, lamivudine, abacavir in Aicardi-Goutières syndrome (AGS), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2015; status: completed.
02
Drugs
zidovudinelamivudineabacavir
03
Conditions
Aicardi-Goutières syndrome (AGS)
Beyond the preview
Go deeper on NCT02363452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02363452.